G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2006
10/24/2006	US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006	US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006	US7125674 Microfabricated flowthrough porous apparatus for discrete detection binding reactions
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125669 Solid-phase immobilization of proteins and peptides
10/24/2006	US7125668 Site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials
10/24/2006	US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006	US7125659 Method and screening candidate compounds for drug against tumor
10/24/2006	US7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/24/2006	US7125592 Detecting interactions at biomimetic interfaces with liquid crystals
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125522 Multiwell apparatus
10/24/2006	US7125517 Kit for a heterogeneous immunoassay for detection of antibodies based on specific antigen-antibody immune complex formation with dually labeled antigen including biotin linked through a polyethylene glycol spacer to albumin
10/24/2006	US7125481 Electrochemical-sensor design
10/24/2006	US7124654 Method for determining a microactuator range of movement
10/24/2006	US7124622 Sensing element for determining a physical property of a gas mixture
10/24/2006	CA2280129C Cell washing device and method
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006	CA2262451C Boronic compound complexing reagents and complexes
10/24/2006	CA2261848C Cell adhesion inhibitors
10/19/2006	WO2006110621A2 Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject
10/19/2006	WO2006110594A2 Sema4d in cancer diagnosis, detection and treatment
10/19/2006	WO2006110585A2 Cancer-related genes (prlr)
10/19/2006	WO2006110581A2 Cancer-related genes
10/19/2006	WO2006110561A2 Methods and compositions for identifying chemical or biological agents using multiplexed labeling and colocalization detection
10/19/2006	WO2006110441A2 Lectin binding to choroidal neovascularization
10/19/2006	WO2006110425A2 Device and methods for detecting an analyte in a sample
10/19/2006	WO2006110339A1 CELLULAR STANDARDS FOR GLYCATED HEMOGLOBIN AlC DETERMINATION
10/19/2006	WO2006110091A1 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
10/19/2006	WO2006110082A1 A method and a kit for diagnosing type 2 diabetes, metabolic syndrome, sub clinical atherosclerosis, myocardial infarct, stroke or clinical manifestations of diabetes.
10/19/2006	WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006	WO2006109793A1 Biomarker for diagnosing heart disease and the use thereof
10/19/2006	WO2006109693A1 Sampling device for viscous sample, method of homogenizing sputum and method of detecting microorganism
10/19/2006	WO2006109685A1 Method for the collection of plasma or serum
10/19/2006	WO2006109599A1 Antibody reactive specifically to age derived from 3,4-dge
10/19/2006	WO2006109544A1 Method for quantitative analysis of metal element contained in resin material
10/19/2006	WO2006109533A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
10/19/2006	WO2006109529A1 Magnetic bead separator
10/19/2006	WO2006109428A1 Compatibility judging system, information processing terminal and storage device for use therein
10/19/2006	WO2006109281A1 Visual display for meter testing bodily fluids
10/19/2006	WO2006109280A2 Method and apparatus for detection of abnormal traces during electrochemical analyte detection
10/19/2006	WO2006109279A2 Analyte determination method and analyte meter
10/19/2006	WO2006109193A2 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof
10/19/2006	WO2006109091A2 Sensitisation of cancer cells to dna replication inhibitors
10/19/2006	WO2006109086A2 Method to predict the sensitivity of tumors to eg5 inhibitors
10/19/2006	WO2006109073A2 Inprovements in or relating to methods and apparatus for analyzing biological samples by mass spectrometry
10/19/2006	WO2006109044A2 Selective modulation of tumour necrosis factor receptors in therapy
10/19/2006	WO2006108908A1 Method and apparatus for dissolving solid matter in liquid
10/19/2006	WO2006108811A1 Analysis device with replaceable test field support
10/19/2006	WO2006108797A1 Analysis device for analysing a liquid sample by means of a test element
10/19/2006	WO2006108718A1 Micro rna
10/19/2006	WO2006108584A2 Human marker genes and agents for cardiovascular disorders and artherosclerosis
10/19/2006	WO2006108582A2 Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
10/19/2006	WO2006108473A1 Method for the determination of cellular transcriptional regulation by micro rnas
10/19/2006	WO2006108248A2 In vitro method for simultaneously detecting and identifying antibiotics of different classes and corresponding diagnostic kit
10/19/2006	WO2006108234A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
10/19/2006	WO2006108225A1 Method of screening for compounds that modulate cell proliferation
10/19/2006	WO2006096735A3 Enhancing a luminescent signal
10/19/2006	WO2006091824A3 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
10/19/2006	WO2006091734A9 Compositions and methods for classifying biological samples
10/19/2006	WO2006089245A3 Bubble architectures and methods of making and using thereof
10/19/2006	WO2006088976A8 Fiber-optic biosensor and biosensing methods
10/19/2006	WO2006088739A8 Assays for detecting the tat protein in hiv-1 infection
10/19/2006	WO2006084130A9 Ultra-sensitive detection systems using multidimension signals
10/19/2006	WO2006077407A3 Modulators of itch ubiquitinase activity
10/19/2006	WO2006077404A3 Cell adhesion by modified cadherin molecules
10/19/2006	WO2006071456A3 Inhibition of hsp27 phosphorylation for treatment of blistering disorders
10/19/2006	WO2006068170A9 Method for improvement of heat stability of glucose dehydrogenase
10/19/2006	WO2006063364A3 Components for gas sensor device
10/19/2006	WO2006063117A3 Identifying cis-regulatory modules by comparative genomics
10/19/2006	WO2006058287A3 Immunologic assay for detection of autoantibodies to folate binding protein
10/19/2006	WO2006052857A3 Biomarker for heart failure
10/19/2006	WO2006051405A3 Methods and means related to cancer stem cells
10/19/2006	WO2006050964A3 Indinavir derivatives useful in immunoassay
10/19/2006	WO2006038798A8 A method of forming a lipid membrane comprising stacked lipid layers, as well as a support provided with a lipid membrane comprising such stacked lipid layers, and the use thereof
10/19/2006	WO2006036388A3 Systems and methods for detecting and analyzing polymers
10/19/2006	WO2006023791A3 Methods and compositions for treating allergic inflammation
10/19/2006	WO2006023593A3 Malarial animal model having a chimeric human liver
10/19/2006	WO2006008294A3 Diagnostic and therapeutic use of slim3 for neurodegenerative diseases
10/19/2006	WO2005123952A3 Particles embedded ina porous substrate for removing target analyte from a sample
10/19/2006	WO2005123951A3 Methods of human leukocyte antigen typing by neighboring single nucleotide polymorphism haplotypes
10/19/2006	WO2005119234B1 Measuring device and methods for use therewith
10/19/2006	WO2005117943A3 Biomarkers for monitoring inhibition of impdh pathway
10/19/2006	WO2005111622A8 Diagnostic assay for trypanosoma cruzi infection
10/19/2006	WO2005094327A9 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
10/19/2006	WO2005092058A3 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
10/19/2006	WO2005088310A9 High throughput glycan microarrays
10/19/2006	WO2005088303A3 Identification and characterization of proteins using new database search modes
10/19/2006	WO2005084188A3 Systemic inflammatory markers and age-related macular degeneration (amd)
10/19/2006	WO2005081783A3 Method for determination and quantification of radiation or genotoxin exposure
10/19/2006	WO2005080593A8 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent
10/19/2006	WO2005074461A3 Kits and methods for autoantibody detection
10/19/2006	WO2005016132A3 Diagnostics for sars virus
10/19/2006	WO2005010484A3 Methods for identifying cell surface receptor protein modulators
10/19/2006	WO2005007878A3 Method of modulating apoptosis and compositions thereof
10/19/2006	WO2004084810A3 Novel imidazoline receptor homologs
10/19/2006	WO2003031932A3 Methods and compositions for detecting colon cancers
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060235646 Methods for eliminating false data from comparative data matrices and for quantifying data matrix quality
10/19/2006	US20060235207 Antibodies against lesion tissue

1 ... 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 ... 3937